SlideShare a Scribd company logo
THE ASSOCIATION BETWEEN SERUM LDL-CHOLESTEROL AND GENETIC VARIATION IN CHROMOSOMAL LOCUS 1P13.3 AMONG CORONARY ARTERY DISEASE PATIENTS IN QATAR Presented by/Huda Ibrahim  Idil Souleman Wais Supervisors/ Dr. Nasser Rizk Dr. Ayman  El Menyar 03/09/11 BIOM 497
Outline ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],03/09/11
Introduction ,[object Object],[object Object],03/09/11
Introduction ,[object Object],03/09/11
Development of Atherosclerosis ,[object Object],[object Object],[object Object],03/09/11
Development of Atherosclerosis ,[object Object],[object Object],[object Object],03/09/11
Development of Atherosclerosis ,[object Object],[object Object],[object Object],[object Object],[object Object],03/09/11
Development of Atherosclerosis ,[object Object],[object Object],03/09/11
Risk Factors ,[object Object],[object Object],[object Object],03/09/11
Risk Factors ,[object Object],[object Object],[object Object],03/09/11
Risk Factors ,[object Object],[object Object],03/09/11
Risk Factors ,[object Object],[object Object],03/09/11
LDL-cholesterol ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],03/09/11 BIOM
[object Object],[object Object],[object Object],03/09/11 BIOM
[object Object],[object Object],[object Object],[object Object],03/09/11 BIOM
Aim of Study ,[object Object],[object Object],03/09/11 BIOM
Experiment Design ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],03/09/11 BIOM497
Approvals ,[object Object],[object Object],[object Object],[object Object],[object Object],03/09/11 BIOM
Methodology  03/09/11
03/09/11
03/09/11
Sample Collection ,[object Object],03/09/11
03/09/11 DNA extracted from whole blood samples of using the QiaAmp DNA blood Mini Kit from Qiagen Cat with RBC lysis  solution Measuring DNA concentration  by using nanodrop Spectrophotometer. All SNPs were genotyped. Polymorphisms of these SNPs carried out by using TaqMan MGB probe by means of an ABI 7500 [Applied Biosystems, Foster City, CA).
Statistical analysis: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],03/09/11
Measurments ,[object Object],[object Object],[object Object],[object Object],[object Object],03/09/11
Results 03/09/11
03/09/11 BIOM Table:1 Variables Group (A)  Group (B) P- value Age 56 (46 – 64) 5  (49 – 61) 0.98 Male Female 22 (84.62%) 4 (15.83%) 16 (100%) 0 - Qatari Non-Qatari 8 (30.8%) 18 (69.2%) 4 (25%) 12 (75%) - BMI  Overweight Obese  27.32 (23.31 – 31.17) 9 (34.6%) 6 (37.5%) 26.96 (24.19 – 32.45) 6 (23.1%) 5 (31.25%) 0.794 0.15 SBP DBP HTN 129.19 (18.57) 75.33 (8.66) 7 (26.9%) 134.56 (15.94) 74.88 (8.57) 6 (37.5%) 0.361 0.874 0.07 DM 12 (46.2%) 8 (50%) 0.81 Glucose (Mm) 7.3 (5.88 – 14.45) 6.6 (5.53 – 9.60) 0.509
03/09/11 BIOM LDL ( <3.37 mmol/L) 3.17 (0.90) 3.44 (1.01) 0.406 HDL (>0.9 mmol/L) 1.03 (0.23) 1.08 (0.24) 0.447 TC (<5.2 mmol/L) 4.89 (0.94) 5.11 (1.40) 0.593 Dyslipdemia  12 (46.2%) 7 (43.75%) 0.58 TG (<2.20 mmol/L) 1.55 (1.06 – 2.18) 1.32 (1.14 – 1.92) 0.637 Insulin (mmol/L) 25.46 (10.12 – 41.83) 4.20  (8.78 – 32.13) 0.484 Troponin (<0.4 ng/mL) 0.35 (0.02 – 2.13) 2.72 (0.37 – 8.24) 0.030 CK-MB (0-3 ng/mL) 11.0 (3.46 – 34.86) 68.0 (5.58 – 266.23) 0.08 On anti-diabetic treatment 10 (38.5%) 10 (62.5%) 0.15 On lipidemic treatment 5 (19.2%) 6(37.5%) 0.22
03/09/11 BIOM Table:2 Genotype distribution --------------------------------------------- Genotype  Group A   Group B lesion <20%  lesion  >20%  n, (%)  n, (%)  P value rs59839 AA AG GG 0 (0.0) 22.0 (88.0) 3.0 (12.0) 1 (6.25) 12.0 (75.0) 3.0 (18.75) 0. 34 rs646776 AA AG GG 10.0 (41.7) 0.0 (0.0) 14.0 (58.3) 8.0 (53.3) 0.0 (0.0) 7.0 (46.7) 0.76 rs4970984 CC CT TT 0.0 (0.0) 25.0 (100) 0.0 (0.0) 0.0 (0.0) 16 (0.0) 0.0 (0.0) 0.21
Results for rs599839  03/09/11 Risk factor Standard  Error [95% CI]  OR P- value Age 0.07 1.04 (0.91-1.20) 0.517 BMI 0.17 0.77 (0.55-1.07) 0.115 Hypertension 1.44 10.6 (0.61-171.06) 0.10 Risk factor Standard  Error [95% CI]  OR P- value Diabetes  1.61 6.49 (0.28-151.81) 0.24 LDL 0.79 0.27(0.02-3.61) 0.33 Dyslipdemia  1.32 0.62(1.32-2.93) 0.54
Results for rs646776  03/09/11 Risk factor Standard  Error Odds Ratio [95% CI] P- value Age 0.04 1.08(0.99-1.19) 0.09 BMI 0.06 1.00(0.90-1.12) 0.94 Hypertension 0.84 0.39(0.08-2.06) 0.27 Risk factor Standard  Error Odds Ratio [95% CI] P- value Diabetes  0.82 1.85(0.37-9.27) 0.44 LDL 0.41 1.40(0.63-3.11) 0.40 Dyslipdemia  0.82 4.24(0.83-21.49) 0.08
Discussion ,[object Object],[object Object],03/09/11 BIOM497
Discussion 03/09/11 BIOM Minor Allele Frequency  – rs599839(A/G) In Qatar <20% lesion  A= 0.44 >20% lesion  A=0.43  Caucasian African American Chinese Japanese 0.32 (G)  0.13 (A)  0.03 (G)  0.08 (G)  Caucasian African American Chinese Japanese 0.28(G)  0.26(G)  0.01(G 0.06 (G)  Caucasian African American Chinese Japanese 0.28 (T)  0.33 (T)  0.02 (T)  0.04 (T)  Minor Allele Frequency  – rs646776(A/G) In Qatar <20% lesion  A= 0.42 >20% lesion  A=0.53  Minor Allele Frequency  –  rs4970984 - (C/T) In Qatar <20% lesion  T= 0.5 >20% lesion  T=0.5
Linkage disequilibrium [LD] of rs599839, rs646776, and rs4970834 03/09/11 BIOM ,[object Object],[object Object],[object Object]
Conclusion ,[object Object],[object Object],03/09/11 BIOM
Limitations  ,[object Object],[object Object],[object Object],03/09/11
Further Study ,[object Object],03/09/11
Acknowledgment ,[object Object],[object Object],[object Object],[object Object],[object Object],03/09/11
References ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],03/09/11
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],03/09/11
[object Object],03/09/11

More Related Content

What's hot

Marc Penn, MD, PhD, FACC - Trials and Tribulations of Assessing CVD Risk in ...
Marc Penn,  MD, PhD, FACC - Trials and Tribulations of Assessing CVD Risk in ...Marc Penn,  MD, PhD, FACC - Trials and Tribulations of Assessing CVD Risk in ...
Marc Penn, MD, PhD, FACC - Trials and Tribulations of Assessing CVD Risk in ...
Cleveland HeartLab, Inc.
 
Omega3 And Heart Health Article Feb 2010
Omega3 And Heart Health Article Feb 2010Omega3 And Heart Health Article Feb 2010
Omega3 And Heart Health Article Feb 2010
NutraceuticalMedicalResearch
 
Raised Lipid Profile In Rheumatoid Arthritis- A Risk For CVD
Raised Lipid Profile In Rheumatoid Arthritis- A Risk For CVDRaised Lipid Profile In Rheumatoid Arthritis- A Risk For CVD
Raised Lipid Profile In Rheumatoid Arthritis- A Risk For CVD
iosrjce
 
Phosphorus levels are associated with subclinical atherosclerosis in the gene...
Phosphorus levels are associated with subclinical atherosclerosis in the gene...Phosphorus levels are associated with subclinical atherosclerosis in the gene...
Phosphorus levels are associated with subclinical atherosclerosis in the gene...
SHAPE Society
 
259 crp as a risk factor
259 crp as a risk factor259 crp as a risk factor
Esv2n47
Esv2n47Esv2n47
Cholesterol Myth and Truth
Cholesterol Myth and TruthCholesterol Myth and Truth
Cholesterol Myth and Truth
FayzaRayes
 
Lung Transplantation For CF
Lung Transplantation For CFLung Transplantation For CF
Lung Transplantation For CF
Spectrum Health System
 
Fernandes
FernandesFernandes
Fatty Acids and their role in Cardiometabolic Health
Fatty Acids and their role in Cardiometabolic HealthFatty Acids and their role in Cardiometabolic Health
Fatty Acids and their role in Cardiometabolic Health
Arindam Pande
 
Primary Prevention of Cardiovascular Disease: The Role of Aspirin and Statins
Primary Prevention of Cardiovascular Disease: The Role of Aspirin and StatinsPrimary Prevention of Cardiovascular Disease: The Role of Aspirin and Statins
Primary Prevention of Cardiovascular Disease: The Role of Aspirin and Statins
CTSI at UCSF
 
What are the clinically important lipoprotein parameters
What are the clinically important lipoprotein parametersWhat are the clinically important lipoprotein parameters
What are the clinically important lipoprotein parameters
EmanSherra
 
Saturated Fat - The Cochrane Collaboration 2012 Review
Saturated Fat - The Cochrane Collaboration 2012 ReviewSaturated Fat - The Cochrane Collaboration 2012 Review
Saturated Fat - The Cochrane Collaboration 2012 Review
Zahccc
 
Lipidomics and Cardiovascular diseases
Lipidomics and Cardiovascular diseasesLipidomics and Cardiovascular diseases
Lipidomics and Cardiovascular diseases
PRAVEEN GUPTA
 
Saturated fat – 2014 Systematic Review and Meta-analysis (Chowdhury)
Saturated fat – 2014 Systematic Review and Meta-analysis (Chowdhury)Saturated fat – 2014 Systematic Review and Meta-analysis (Chowdhury)
Saturated fat – 2014 Systematic Review and Meta-analysis (Chowdhury)
Zahccc
 
Using Microsimulation to inform Targeted Cardiovascular Disease Prevention Po...
Using Microsimulation to inform Targeted Cardiovascular Disease Prevention Po...Using Microsimulation to inform Targeted Cardiovascular Disease Prevention Po...
Using Microsimulation to inform Targeted Cardiovascular Disease Prevention Po...
HMO Research Network
 
Health Economics and Outcomes Research: Minimizing Uncertainty
Health Economics and Outcomes Research: Minimizing Uncertainty Health Economics and Outcomes Research: Minimizing Uncertainty
Health Economics and Outcomes Research: Minimizing Uncertainty
Robert Simons
 
LDL Cholesterol Target :“ Lower the Better ”
LDL Cholesterol Target :“ Lower the Better ”LDL Cholesterol Target :“ Lower the Better ”
LDL Cholesterol Target :“ Lower the Better ”
Arindam Pande
 

What's hot (18)

Marc Penn, MD, PhD, FACC - Trials and Tribulations of Assessing CVD Risk in ...
Marc Penn,  MD, PhD, FACC - Trials and Tribulations of Assessing CVD Risk in ...Marc Penn,  MD, PhD, FACC - Trials and Tribulations of Assessing CVD Risk in ...
Marc Penn, MD, PhD, FACC - Trials and Tribulations of Assessing CVD Risk in ...
 
Omega3 And Heart Health Article Feb 2010
Omega3 And Heart Health Article Feb 2010Omega3 And Heart Health Article Feb 2010
Omega3 And Heart Health Article Feb 2010
 
Raised Lipid Profile In Rheumatoid Arthritis- A Risk For CVD
Raised Lipid Profile In Rheumatoid Arthritis- A Risk For CVDRaised Lipid Profile In Rheumatoid Arthritis- A Risk For CVD
Raised Lipid Profile In Rheumatoid Arthritis- A Risk For CVD
 
Phosphorus levels are associated with subclinical atherosclerosis in the gene...
Phosphorus levels are associated with subclinical atherosclerosis in the gene...Phosphorus levels are associated with subclinical atherosclerosis in the gene...
Phosphorus levels are associated with subclinical atherosclerosis in the gene...
 
259 crp as a risk factor
259 crp as a risk factor259 crp as a risk factor
259 crp as a risk factor
 
Esv2n47
Esv2n47Esv2n47
Esv2n47
 
Cholesterol Myth and Truth
Cholesterol Myth and TruthCholesterol Myth and Truth
Cholesterol Myth and Truth
 
Lung Transplantation For CF
Lung Transplantation For CFLung Transplantation For CF
Lung Transplantation For CF
 
Fernandes
FernandesFernandes
Fernandes
 
Fatty Acids and their role in Cardiometabolic Health
Fatty Acids and their role in Cardiometabolic HealthFatty Acids and their role in Cardiometabolic Health
Fatty Acids and their role in Cardiometabolic Health
 
Primary Prevention of Cardiovascular Disease: The Role of Aspirin and Statins
Primary Prevention of Cardiovascular Disease: The Role of Aspirin and StatinsPrimary Prevention of Cardiovascular Disease: The Role of Aspirin and Statins
Primary Prevention of Cardiovascular Disease: The Role of Aspirin and Statins
 
What are the clinically important lipoprotein parameters
What are the clinically important lipoprotein parametersWhat are the clinically important lipoprotein parameters
What are the clinically important lipoprotein parameters
 
Saturated Fat - The Cochrane Collaboration 2012 Review
Saturated Fat - The Cochrane Collaboration 2012 ReviewSaturated Fat - The Cochrane Collaboration 2012 Review
Saturated Fat - The Cochrane Collaboration 2012 Review
 
Lipidomics and Cardiovascular diseases
Lipidomics and Cardiovascular diseasesLipidomics and Cardiovascular diseases
Lipidomics and Cardiovascular diseases
 
Saturated fat – 2014 Systematic Review and Meta-analysis (Chowdhury)
Saturated fat – 2014 Systematic Review and Meta-analysis (Chowdhury)Saturated fat – 2014 Systematic Review and Meta-analysis (Chowdhury)
Saturated fat – 2014 Systematic Review and Meta-analysis (Chowdhury)
 
Using Microsimulation to inform Targeted Cardiovascular Disease Prevention Po...
Using Microsimulation to inform Targeted Cardiovascular Disease Prevention Po...Using Microsimulation to inform Targeted Cardiovascular Disease Prevention Po...
Using Microsimulation to inform Targeted Cardiovascular Disease Prevention Po...
 
Health Economics and Outcomes Research: Minimizing Uncertainty
Health Economics and Outcomes Research: Minimizing Uncertainty Health Economics and Outcomes Research: Minimizing Uncertainty
Health Economics and Outcomes Research: Minimizing Uncertainty
 
LDL Cholesterol Target :“ Lower the Better ”
LDL Cholesterol Target :“ Lower the Better ”LDL Cholesterol Target :“ Lower the Better ”
LDL Cholesterol Target :“ Lower the Better ”
 

Viewers also liked

Blankenberg
BlankenbergBlankenberg
Platelets 2
Platelets 2Platelets 2
Platelets 2
arez10
 
New types of biomarkers in the cardiovascular sistem corectat
New types of biomarkers in the cardiovascular sistem corectatNew types of biomarkers in the cardiovascular sistem corectat
New types of biomarkers in the cardiovascular sistem corectat
Florin George Frunza
 
197 reducing atherosclerosis in mice
197 reducing atherosclerosis in mice197 reducing atherosclerosis in mice
197 reducing atherosclerosis in mice
Society for Heart Attack Prevention and Eradication
 
212 basic molecular genetic studies in atherosclerosis
212 basic molecular genetic studies in atherosclerosis212 basic molecular genetic studies in atherosclerosis
212 basic molecular genetic studies in atherosclerosis
Society for Heart Attack Prevention and Eradication
 
Es v2n43
Es v2n43Es v2n43
Platelet activating factors by aisha siddiqui
Platelet activating factors by aisha siddiquiPlatelet activating factors by aisha siddiqui
Platelet activating factors by aisha siddiqui
AISHASID
 
Cardiovascular genetics
Cardiovascular geneticsCardiovascular genetics
Cardiovascular genetics
Toufiqur Rahman
 
Coagulation
CoagulationCoagulation
Coagulation
raj kumar
 
Biomarker ppts of cnu
Biomarker ppts of cnuBiomarker ppts of cnu
Biomarker ppts of cnu
sravanponnam
 
Cardiovascular system/ diagnostic tests and procedures
Cardiovascular system/ diagnostic tests and proceduresCardiovascular system/ diagnostic tests and procedures
Cardiovascular system/ diagnostic tests and procedures
Mila Kilanski
 
Cardiac Biomarkers
Cardiac BiomarkersCardiac Biomarkers
Cardiac Biomarkers
Prabhash Bhavsar
 
Single nucleotide polymorphism
Single nucleotide polymorphismSingle nucleotide polymorphism
Single nucleotide polymorphism
Bipul Das
 
Genetic polymorphism
Genetic polymorphismGenetic polymorphism
Genetic polymorphism
Dandu Prasad Reddy
 
Cardiovascular Disease.ppt
Cardiovascular Disease.pptCardiovascular Disease.ppt
Cardiovascular Disease.ppt
Shama
 

Viewers also liked (15)

Blankenberg
BlankenbergBlankenberg
Blankenberg
 
Platelets 2
Platelets 2Platelets 2
Platelets 2
 
New types of biomarkers in the cardiovascular sistem corectat
New types of biomarkers in the cardiovascular sistem corectatNew types of biomarkers in the cardiovascular sistem corectat
New types of biomarkers in the cardiovascular sistem corectat
 
197 reducing atherosclerosis in mice
197 reducing atherosclerosis in mice197 reducing atherosclerosis in mice
197 reducing atherosclerosis in mice
 
212 basic molecular genetic studies in atherosclerosis
212 basic molecular genetic studies in atherosclerosis212 basic molecular genetic studies in atherosclerosis
212 basic molecular genetic studies in atherosclerosis
 
Es v2n43
Es v2n43Es v2n43
Es v2n43
 
Platelet activating factors by aisha siddiqui
Platelet activating factors by aisha siddiquiPlatelet activating factors by aisha siddiqui
Platelet activating factors by aisha siddiqui
 
Cardiovascular genetics
Cardiovascular geneticsCardiovascular genetics
Cardiovascular genetics
 
Coagulation
CoagulationCoagulation
Coagulation
 
Biomarker ppts of cnu
Biomarker ppts of cnuBiomarker ppts of cnu
Biomarker ppts of cnu
 
Cardiovascular system/ diagnostic tests and procedures
Cardiovascular system/ diagnostic tests and proceduresCardiovascular system/ diagnostic tests and procedures
Cardiovascular system/ diagnostic tests and procedures
 
Cardiac Biomarkers
Cardiac BiomarkersCardiac Biomarkers
Cardiac Biomarkers
 
Single nucleotide polymorphism
Single nucleotide polymorphismSingle nucleotide polymorphism
Single nucleotide polymorphism
 
Genetic polymorphism
Genetic polymorphismGenetic polymorphism
Genetic polymorphism
 
Cardiovascular Disease.ppt
Cardiovascular Disease.pptCardiovascular Disease.ppt
Cardiovascular Disease.ppt
 

Similar to Research project.ppt idil_&_huda

Mean platelet volume and other platelet volume indices in patients with acute...
Mean platelet volume and other platelet volume indices in patients with acute...Mean platelet volume and other platelet volume indices in patients with acute...
Mean platelet volume and other platelet volume indices in patients with acute...
iosrjce
 
International Journal of Nephrology & Therapeutics
International Journal of Nephrology & TherapeuticsInternational Journal of Nephrology & Therapeutics
International Journal of Nephrology & Therapeutics
SciRes Literature LLC. | Open Access Journals
 
HIGH SENSITIVE C-REACTIVE PROTEIN (hs-CRP) AND ITS CORRELATION WITH ANGIOGRAP...
HIGH SENSITIVE C-REACTIVE PROTEIN (hs-CRP) AND ITS CORRELATION WITH ANGIOGRAP...HIGH SENSITIVE C-REACTIVE PROTEIN (hs-CRP) AND ITS CORRELATION WITH ANGIOGRAP...
HIGH SENSITIVE C-REACTIVE PROTEIN (hs-CRP) AND ITS CORRELATION WITH ANGIOGRAP...
M A Hasnat
 
J dhaka med coll. 2010 19(2) 91 97.
J dhaka med coll. 2010  19(2) 91 97.J dhaka med coll. 2010  19(2) 91 97.
J dhaka med coll. 2010 19(2) 91 97.
DrMAHasnat
 
Impact of obesity on cardiometabolic risk: Will we lose the battle?
Impact of obesity on cardiometabolic risk: Will we lose the battle?Impact of obesity on cardiometabolic risk: Will we lose the battle?
Impact of obesity on cardiometabolic risk: Will we lose the battle?
My Healthy Waist
 
2659.full
2659.full2659.full
2659.full
Michael Page
 
Qualitative Flow Cytometric Analysis of Malaysian
Qualitative Flow Cytometric Analysis of MalaysianQualitative Flow Cytometric Analysis of Malaysian
Qualitative Flow Cytometric Analysis of Malaysian
Mohadese Hashem Boroojerdi
 
aspirin effect on urinary thromboxane
aspirin effect on urinary thromboxaneaspirin effect on urinary thromboxane
aspirin effect on urinary thromboxane
guestfb7a
 
Dyslipidemia -Assessment and management based on evidence
Dyslipidemia -Assessment and management based on evidence  Dyslipidemia -Assessment and management based on evidence
Dyslipidemia -Assessment and management based on evidence
SYEDRAZA56411
 
CoronaryArteryDisease.ppt
CoronaryArteryDisease.pptCoronaryArteryDisease.ppt
CoronaryArteryDisease.ppt
ssuser326cf4
 
CoronaryArteryDisease.ppt
CoronaryArteryDisease.pptCoronaryArteryDisease.ppt
CoronaryArteryDisease.ppt
Sani191640
 
Acs ppt
Acs pptAcs ppt
Acs ppt
Acs pptAcs ppt
AML: improving standard therapy
AML: improving standard therapyAML: improving standard therapy
AML: improving standard therapy
Pritish Chandra Patra
 
Blood sugar
Blood sugarBlood sugar
Blood sugar
DMS Library
 
Metabolic syndrome vs HbA1c
Metabolic syndrome vs HbA1cMetabolic syndrome vs HbA1c
Metabolic syndrome vs HbA1c
Tanveer Fahim
 
Phosphate Levels are Associated with Presence of Carotid Artery 5.6.09
Phosphate Levels are Associated with Presence of Carotid Artery 5.6.09Phosphate Levels are Associated with Presence of Carotid Artery 5.6.09
Phosphate Levels are Associated with Presence of Carotid Artery 5.6.09
Leonard Davis Institute of Health Economics
 
Assessment of the Risk of Myocardial Infarction among Undergraduate Students ...
Assessment of the Risk of Myocardial Infarction among Undergraduate Students ...Assessment of the Risk of Myocardial Infarction among Undergraduate Students ...
Assessment of the Risk of Myocardial Infarction among Undergraduate Students ...
Healthcare and Medical Sciences
 
Osteoporosis 2016 | Antidiabetic medication use and the risk of fracture amon...
Osteoporosis 2016 | Antidiabetic medication use and the risk of fracture amon...Osteoporosis 2016 | Antidiabetic medication use and the risk of fracture amon...
Osteoporosis 2016 | Antidiabetic medication use and the risk of fracture amon...
National Osteoporosis Society
 
Human Genetics Paper
Human Genetics PaperHuman Genetics Paper
Human Genetics Paper
Joseph Thompson
 

Similar to Research project.ppt idil_&_huda (20)

Mean platelet volume and other platelet volume indices in patients with acute...
Mean platelet volume and other platelet volume indices in patients with acute...Mean platelet volume and other platelet volume indices in patients with acute...
Mean platelet volume and other platelet volume indices in patients with acute...
 
International Journal of Nephrology & Therapeutics
International Journal of Nephrology & TherapeuticsInternational Journal of Nephrology & Therapeutics
International Journal of Nephrology & Therapeutics
 
HIGH SENSITIVE C-REACTIVE PROTEIN (hs-CRP) AND ITS CORRELATION WITH ANGIOGRAP...
HIGH SENSITIVE C-REACTIVE PROTEIN (hs-CRP) AND ITS CORRELATION WITH ANGIOGRAP...HIGH SENSITIVE C-REACTIVE PROTEIN (hs-CRP) AND ITS CORRELATION WITH ANGIOGRAP...
HIGH SENSITIVE C-REACTIVE PROTEIN (hs-CRP) AND ITS CORRELATION WITH ANGIOGRAP...
 
J dhaka med coll. 2010 19(2) 91 97.
J dhaka med coll. 2010  19(2) 91 97.J dhaka med coll. 2010  19(2) 91 97.
J dhaka med coll. 2010 19(2) 91 97.
 
Impact of obesity on cardiometabolic risk: Will we lose the battle?
Impact of obesity on cardiometabolic risk: Will we lose the battle?Impact of obesity on cardiometabolic risk: Will we lose the battle?
Impact of obesity on cardiometabolic risk: Will we lose the battle?
 
2659.full
2659.full2659.full
2659.full
 
Qualitative Flow Cytometric Analysis of Malaysian
Qualitative Flow Cytometric Analysis of MalaysianQualitative Flow Cytometric Analysis of Malaysian
Qualitative Flow Cytometric Analysis of Malaysian
 
aspirin effect on urinary thromboxane
aspirin effect on urinary thromboxaneaspirin effect on urinary thromboxane
aspirin effect on urinary thromboxane
 
Dyslipidemia -Assessment and management based on evidence
Dyslipidemia -Assessment and management based on evidence  Dyslipidemia -Assessment and management based on evidence
Dyslipidemia -Assessment and management based on evidence
 
CoronaryArteryDisease.ppt
CoronaryArteryDisease.pptCoronaryArteryDisease.ppt
CoronaryArteryDisease.ppt
 
CoronaryArteryDisease.ppt
CoronaryArteryDisease.pptCoronaryArteryDisease.ppt
CoronaryArteryDisease.ppt
 
Acs ppt
Acs pptAcs ppt
Acs ppt
 
Acs ppt
Acs pptAcs ppt
Acs ppt
 
AML: improving standard therapy
AML: improving standard therapyAML: improving standard therapy
AML: improving standard therapy
 
Blood sugar
Blood sugarBlood sugar
Blood sugar
 
Metabolic syndrome vs HbA1c
Metabolic syndrome vs HbA1cMetabolic syndrome vs HbA1c
Metabolic syndrome vs HbA1c
 
Phosphate Levels are Associated with Presence of Carotid Artery 5.6.09
Phosphate Levels are Associated with Presence of Carotid Artery 5.6.09Phosphate Levels are Associated with Presence of Carotid Artery 5.6.09
Phosphate Levels are Associated with Presence of Carotid Artery 5.6.09
 
Assessment of the Risk of Myocardial Infarction among Undergraduate Students ...
Assessment of the Risk of Myocardial Infarction among Undergraduate Students ...Assessment of the Risk of Myocardial Infarction among Undergraduate Students ...
Assessment of the Risk of Myocardial Infarction among Undergraduate Students ...
 
Osteoporosis 2016 | Antidiabetic medication use and the risk of fracture amon...
Osteoporosis 2016 | Antidiabetic medication use and the risk of fracture amon...Osteoporosis 2016 | Antidiabetic medication use and the risk of fracture amon...
Osteoporosis 2016 | Antidiabetic medication use and the risk of fracture amon...
 
Human Genetics Paper
Human Genetics PaperHuman Genetics Paper
Human Genetics Paper
 

Recently uploaded

Mule event processing models | MuleSoft Mysore Meetup #47
Mule event processing models | MuleSoft Mysore Meetup #47Mule event processing models | MuleSoft Mysore Meetup #47
Mule event processing models | MuleSoft Mysore Meetup #47
MysoreMuleSoftMeetup
 
Lifelines of National Economy chapter for Class 10 STUDY MATERIAL PDF
Lifelines of National Economy chapter for Class 10 STUDY MATERIAL PDFLifelines of National Economy chapter for Class 10 STUDY MATERIAL PDF
Lifelines of National Economy chapter for Class 10 STUDY MATERIAL PDF
Vivekanand Anglo Vedic Academy
 
Stack Memory Organization of 8086 Microprocessor
Stack Memory Organization of 8086 MicroprocessorStack Memory Organization of 8086 Microprocessor
Stack Memory Organization of 8086 Microprocessor
JomonJoseph58
 
How to Make a Field Mandatory in Odoo 17
How to Make a Field Mandatory in Odoo 17How to Make a Field Mandatory in Odoo 17
How to Make a Field Mandatory in Odoo 17
Celine George
 
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptxC1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
mulvey2
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
Nicholas Montgomery
 
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptxNEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
iammrhaywood
 
Leveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit InnovationLeveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit Innovation
TechSoup
 
Electric Fetus - Record Store Scavenger Hunt
Electric Fetus - Record Store Scavenger HuntElectric Fetus - Record Store Scavenger Hunt
Electric Fetus - Record Store Scavenger Hunt
RamseyBerglund
 
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
imrankhan141184
 
Pharmaceutics Pharmaceuticals best of brub
Pharmaceutics Pharmaceuticals best of brubPharmaceutics Pharmaceuticals best of brub
Pharmaceutics Pharmaceuticals best of brub
danielkiash986
 
RESULTS OF THE EVALUATION QUESTIONNAIRE.pptx
RESULTS OF THE EVALUATION QUESTIONNAIRE.pptxRESULTS OF THE EVALUATION QUESTIONNAIRE.pptx
RESULTS OF THE EVALUATION QUESTIONNAIRE.pptx
zuzanka
 
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptxBeyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
EduSkills OECD
 
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.ppt
Level 3 NCEA - NZ: A  Nation In the Making 1872 - 1900 SML.pptLevel 3 NCEA - NZ: A  Nation In the Making 1872 - 1900 SML.ppt
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.ppt
Henry Hollis
 
Gender and Mental Health - Counselling and Family Therapy Applications and In...
Gender and Mental Health - Counselling and Family Therapy Applications and In...Gender and Mental Health - Counselling and Family Therapy Applications and In...
Gender and Mental Health - Counselling and Family Therapy Applications and In...
PsychoTech Services
 
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
PECB
 
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdfمصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
سمير بسيوني
 
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
Nguyen Thanh Tu Collection
 
Nutrition Inc FY 2024, 4 - Hour Training
Nutrition Inc FY 2024, 4 - Hour TrainingNutrition Inc FY 2024, 4 - Hour Training
Nutrition Inc FY 2024, 4 - Hour Training
melliereed
 
BBR 2024 Summer Sessions Interview Training
BBR  2024 Summer Sessions Interview TrainingBBR  2024 Summer Sessions Interview Training
BBR 2024 Summer Sessions Interview Training
Katrina Pritchard
 

Recently uploaded (20)

Mule event processing models | MuleSoft Mysore Meetup #47
Mule event processing models | MuleSoft Mysore Meetup #47Mule event processing models | MuleSoft Mysore Meetup #47
Mule event processing models | MuleSoft Mysore Meetup #47
 
Lifelines of National Economy chapter for Class 10 STUDY MATERIAL PDF
Lifelines of National Economy chapter for Class 10 STUDY MATERIAL PDFLifelines of National Economy chapter for Class 10 STUDY MATERIAL PDF
Lifelines of National Economy chapter for Class 10 STUDY MATERIAL PDF
 
Stack Memory Organization of 8086 Microprocessor
Stack Memory Organization of 8086 MicroprocessorStack Memory Organization of 8086 Microprocessor
Stack Memory Organization of 8086 Microprocessor
 
How to Make a Field Mandatory in Odoo 17
How to Make a Field Mandatory in Odoo 17How to Make a Field Mandatory in Odoo 17
How to Make a Field Mandatory in Odoo 17
 
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptxC1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
 
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptxNEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
 
Leveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit InnovationLeveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit Innovation
 
Electric Fetus - Record Store Scavenger Hunt
Electric Fetus - Record Store Scavenger HuntElectric Fetus - Record Store Scavenger Hunt
Electric Fetus - Record Store Scavenger Hunt
 
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
 
Pharmaceutics Pharmaceuticals best of brub
Pharmaceutics Pharmaceuticals best of brubPharmaceutics Pharmaceuticals best of brub
Pharmaceutics Pharmaceuticals best of brub
 
RESULTS OF THE EVALUATION QUESTIONNAIRE.pptx
RESULTS OF THE EVALUATION QUESTIONNAIRE.pptxRESULTS OF THE EVALUATION QUESTIONNAIRE.pptx
RESULTS OF THE EVALUATION QUESTIONNAIRE.pptx
 
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptxBeyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptx
 
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.ppt
Level 3 NCEA - NZ: A  Nation In the Making 1872 - 1900 SML.pptLevel 3 NCEA - NZ: A  Nation In the Making 1872 - 1900 SML.ppt
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.ppt
 
Gender and Mental Health - Counselling and Family Therapy Applications and In...
Gender and Mental Health - Counselling and Family Therapy Applications and In...Gender and Mental Health - Counselling and Family Therapy Applications and In...
Gender and Mental Health - Counselling and Family Therapy Applications and In...
 
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
 
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdfمصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
 
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
 
Nutrition Inc FY 2024, 4 - Hour Training
Nutrition Inc FY 2024, 4 - Hour TrainingNutrition Inc FY 2024, 4 - Hour Training
Nutrition Inc FY 2024, 4 - Hour Training
 
BBR 2024 Summer Sessions Interview Training
BBR  2024 Summer Sessions Interview TrainingBBR  2024 Summer Sessions Interview Training
BBR 2024 Summer Sessions Interview Training
 

Research project.ppt idil_&_huda

  • 1. THE ASSOCIATION BETWEEN SERUM LDL-CHOLESTEROL AND GENETIC VARIATION IN CHROMOSOMAL LOCUS 1P13.3 AMONG CORONARY ARTERY DISEASE PATIENTS IN QATAR Presented by/Huda Ibrahim Idil Souleman Wais Supervisors/ Dr. Nasser Rizk Dr. Ayman El Menyar 03/09/11 BIOM 497
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 22.
  • 23. 03/09/11 DNA extracted from whole blood samples of using the QiaAmp DNA blood Mini Kit from Qiagen Cat with RBC lysis solution Measuring DNA concentration by using nanodrop Spectrophotometer. All SNPs were genotyped. Polymorphisms of these SNPs carried out by using TaqMan MGB probe by means of an ABI 7500 [Applied Biosystems, Foster City, CA).
  • 24.
  • 25.
  • 27. 03/09/11 BIOM Table:1 Variables Group (A) Group (B) P- value Age 56 (46 – 64) 5 (49 – 61) 0.98 Male Female 22 (84.62%) 4 (15.83%) 16 (100%) 0 - Qatari Non-Qatari 8 (30.8%) 18 (69.2%) 4 (25%) 12 (75%) - BMI Overweight Obese 27.32 (23.31 – 31.17) 9 (34.6%) 6 (37.5%) 26.96 (24.19 – 32.45) 6 (23.1%) 5 (31.25%) 0.794 0.15 SBP DBP HTN 129.19 (18.57) 75.33 (8.66) 7 (26.9%) 134.56 (15.94) 74.88 (8.57) 6 (37.5%) 0.361 0.874 0.07 DM 12 (46.2%) 8 (50%) 0.81 Glucose (Mm) 7.3 (5.88 – 14.45) 6.6 (5.53 – 9.60) 0.509
  • 28. 03/09/11 BIOM LDL ( <3.37 mmol/L) 3.17 (0.90) 3.44 (1.01) 0.406 HDL (>0.9 mmol/L) 1.03 (0.23) 1.08 (0.24) 0.447 TC (<5.2 mmol/L) 4.89 (0.94) 5.11 (1.40) 0.593 Dyslipdemia 12 (46.2%) 7 (43.75%) 0.58 TG (<2.20 mmol/L) 1.55 (1.06 – 2.18) 1.32 (1.14 – 1.92) 0.637 Insulin (mmol/L) 25.46 (10.12 – 41.83) 4.20 (8.78 – 32.13) 0.484 Troponin (<0.4 ng/mL) 0.35 (0.02 – 2.13) 2.72 (0.37 – 8.24) 0.030 CK-MB (0-3 ng/mL) 11.0 (3.46 – 34.86) 68.0 (5.58 – 266.23) 0.08 On anti-diabetic treatment 10 (38.5%) 10 (62.5%) 0.15 On lipidemic treatment 5 (19.2%) 6(37.5%) 0.22
  • 29. 03/09/11 BIOM Table:2 Genotype distribution --------------------------------------------- Genotype Group A Group B lesion <20% lesion >20% n, (%) n, (%) P value rs59839 AA AG GG 0 (0.0) 22.0 (88.0) 3.0 (12.0) 1 (6.25) 12.0 (75.0) 3.0 (18.75) 0. 34 rs646776 AA AG GG 10.0 (41.7) 0.0 (0.0) 14.0 (58.3) 8.0 (53.3) 0.0 (0.0) 7.0 (46.7) 0.76 rs4970984 CC CT TT 0.0 (0.0) 25.0 (100) 0.0 (0.0) 0.0 (0.0) 16 (0.0) 0.0 (0.0) 0.21
  • 30. Results for rs599839 03/09/11 Risk factor Standard Error [95% CI] OR P- value Age 0.07 1.04 (0.91-1.20) 0.517 BMI 0.17 0.77 (0.55-1.07) 0.115 Hypertension 1.44 10.6 (0.61-171.06) 0.10 Risk factor Standard Error [95% CI] OR P- value Diabetes 1.61 6.49 (0.28-151.81) 0.24 LDL 0.79 0.27(0.02-3.61) 0.33 Dyslipdemia 1.32 0.62(1.32-2.93) 0.54
  • 31. Results for rs646776 03/09/11 Risk factor Standard Error Odds Ratio [95% CI] P- value Age 0.04 1.08(0.99-1.19) 0.09 BMI 0.06 1.00(0.90-1.12) 0.94 Hypertension 0.84 0.39(0.08-2.06) 0.27 Risk factor Standard Error Odds Ratio [95% CI] P- value Diabetes 0.82 1.85(0.37-9.27) 0.44 LDL 0.41 1.40(0.63-3.11) 0.40 Dyslipdemia 0.82 4.24(0.83-21.49) 0.08
  • 32.
  • 33. Discussion 03/09/11 BIOM Minor Allele Frequency – rs599839(A/G) In Qatar <20% lesion A= 0.44 >20% lesion A=0.43 Caucasian African American Chinese Japanese 0.32 (G)  0.13 (A)  0.03 (G)  0.08 (G)  Caucasian African American Chinese Japanese 0.28(G)  0.26(G)  0.01(G 0.06 (G)  Caucasian African American Chinese Japanese 0.28 (T)  0.33 (T)  0.02 (T)  0.04 (T)  Minor Allele Frequency – rs646776(A/G) In Qatar <20% lesion A= 0.42 >20% lesion A=0.53 Minor Allele Frequency – rs4970984 - (C/T) In Qatar <20% lesion T= 0.5 >20% lesion T=0.5
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.

Editor's Notes

  1. Our research aims to focus on precisely this issue. We wanted to test this finding further to see if a similar association could be reported in the Qatari population